Skip to main content

Risk for Long COVID Lower in Pregnant Individuals

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 9, 2025.

via HealthDay

WEDNESDAY, April 9, 2025 -- The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to a study published online April 1 in Nature Communications.

Chengxi Zang, Ph.D., from Weill Cornell Medicine in New York City, and colleagues compared long COVID risk in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy versus reproductive-age women infected outside of pregnancy. The analysis included 29,975 pregnant individuals (aged 18 to 50 years) with SARS-CoV-2 infection in pregnancy identified from the National Patient-Centered Clinical Research Network (PCORnet) and 42,176 from the National COVID Cohort Collaborative (N3C) between March 2020 and June 2023.

The researchers found that at 180 days after infection, estimated long COVID risks for those infected during pregnancy were 16.47 per 100 persons in PCORnet and 4.37 per 100 persons in N3C. Risks were lower compared with matched nonpregnant individuals in both datasets (adjusted hazard ratios for long COVID were 0.86 and 0.70, respectively). Black race/ethnicity, advanced maternal age, first- and second-trimester infection, obesity, and comorbid conditions were risk factors for long COVID.

"The similar patterns and triangulation from different long COVID definitions across two different cohorts further strengthen the confidence in these findings," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Specific Antiseizure Medications Associated With Major Malformations in Infants

FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...

ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes

FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...

Risk for Severe COVID-19 Elevated for Childhood Cancer Survivors

FRIDAY, July 11, 2025 -- Childhood cancer survivors have a lower risk for registered COVID-19 infection but a higher risk for severe COVID-19, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.